IBA - Regulated Information
02 October 2024 - 2:00AM
UK Regulatory
IBA - Regulated Information
(Article 14, paragraph 1 of the law of 2
May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, October 1st,
2024 06:00
Summary of the notification
IBA (Ion Beam Applications), the world’s leading
provider of proton therapy solutions for the treatment of cancer,
announces that it has to issue a transparency notification, in
accordance with Article 14, al. 1 of the Transparency Law of May 2,
2007 on disclosure of major holdings, further to the notification
received on September 26, 2024.
In its notification, Vallcara Limited indicated
that following an acquisition of securities or voting
rights. Its total participation in IBA SA increased and its
participation in IBA shares with voting rights crossed the
threshold of 3% on 24/09/2024.
Content of the notification
- Reason for the notification: Acquisition or disposal of
securities or voting rights
- Notification by: A parent company or controlling
person
- Persons subject to the notification
requirement:
- Date on which the threshold is crossed: 24/09/2024
- Threshold crossed (in %) : 3%
- Denominator : 40.595.290
- Notified details: (extract of the received notification
form)
- Full chain of controlled undertakings through which the
holding is effectively held
Vallcara Limited is 100% owned by Vallgesa
Limited (C 58154), a company registered in Malta. Vallgesa Limited
is not a controlled entity.
Vallcara Limited has reached the 3% notification
threshold following the acquisition of shares. Vallcara Limited is
the investment manager who can exercise voting rights at its
discretion in the absence of specific.
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 2.000 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
For further information, please
contact:
Valérie Van Impe
Paralegal
+32479267809
legal@iba-group.com
- 20241001-IBA-Vallcara_transparency EN
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From Dec 2023 to Dec 2024